Clinical Trials Browser

Phase 1 × Active not recruiting × midostaurin × Clear all

NCT00819546 2025-02-27

RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS

Phase 1 Active not recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute